Payment overview · 2025
General Payments
$22.54
1 reported records · 1 companies
Healthcare provider profile · identity verified
Kenneth L Scott, DO
Allopathic & Osteopathic Physicians|Hospitalist · CHATTANOOGA, TN · NPI 1083699524
Verified facts
What the public records show
CMS Open Payments records show Kenneth L Scott, DO received $22.54 in general payments during 2025 across 1 reported records.
LivaNova USA, Inc. accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| LivaNova USA, Inc. | Unresolved — no canonical attribution shown | $22.54 | 100.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $22.54 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| VNS THERAPY SENTIVA MODEL 1000 GENERATOR Normalized: vns therapy sentiva model 1000 generator |
Device | LivaNova USA, Inc. | $22.54 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
None of this doctor’s payer companies has same-entity product evidence that passes the publication threshold. The site does not infer company ownership, affiliates, or generic manufacturers.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 303 | 38 |
| Sertraline Hcl | Sertraline Hcl | 297 | 37 |
| Famotidine | Famotidine | 273 | 35 |
| Gabapentin | Gabapentin | 247 | 32 |
| Amlodipine Besylate | Amlodipine Besylate | 217 | 27 |
| Donepezil Hcl | Donepezil Hcl | 197 | 22 |
| Quetiapine Fumarate | Quetiapine Fumarate | 163 | 19 |
| Tamsulosin Hcl | Tamsulosin Hcl | 157 | 20 |
| Levothyroxine Sodium | Levothyroxine Sodium | 156 | 17 |
| Mirtazapine | Mirtazapine | 153 | 24 |
| Lactulose | Lactulose | 143 | 31 |
| Metformin Hcl | Metformin Hcl | 137 | 18 |
| Potassium Chloride | Potassium Chloride | 136 | 22 |
| Lisinopril | Lisinopril | 127 | 16 |
| Fentanyl | Fentanyl | 116 | suppressed |
| Metoprolol Tartrate | Metoprolol Tartrate | 105 | 15 |
| Duloxetine Hcl | Duloxetine Hcl | 99 | 12 |
| Finasteride | Finasteride | 98 | 11 |
| Furosemide | Furosemide | 95 | 15 |
| Oxycodone Hcl | Oxycodone Hcl | 93 | 14 |
| Eliquis | Apixaban | 89 | 15 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 83 | 28 |
| Pantoprazole Sodium | Pantoprazole Sodium | 83 | 22 |
| Clopidogrel | Clopidogrel Bisulfate | 81 | suppressed |
| Metoprolol Succinate | Metoprolol Succinate | 77 | 13 |
| Keppra | Levetiracetam | 73 | suppressed |
| Memantine Hcl | Memantine Hcl | 72 | suppressed |
| Chlorhexidine Gluconate | Chlorhexidine Gluconate | 71 | suppressed |
| Citalopram Hbr | Citalopram Hydrobromide | 70 | suppressed |
| Levetiracetam | Levetiracetam | 70 | suppressed |
| Trazodone Hcl | Trazodone Hcl | 69 | 11 |
| Klayesta | Nystatin | 64 | 33 |
| Losartan Potassium | Losartan Potassium | 63 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 62 | suppressed |
| Autoshield Duo Pen Needle | Pen Needle,dual Safety,diabetc | 58 | suppressed |
| Baclofen | Baclofen | 50 | suppressed |
| Divalproex Sodium | Divalproex Sodium | 50 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 46 | suppressed |
| Lacosamide | Lacosamide | 46 | suppressed |
| Briviact | Brivaracetam | 43 | suppressed |
| Sodium Chloride | 0.9 % Sodium Chloride | 43 | 26 |
| Celecoxib | Celecoxib | 42 | suppressed |
| Digoxin | Digoxin | 42 | suppressed |
| Hydrocortisone | Hydrocortisone | 40 | suppressed |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 40 | 27 |
| Prednisone | Prednisone | 38 | suppressed |
| Aripiprazole | Aripiprazole | 36 | suppressed |
| Carvedilol | Carvedilol | 36 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 35 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 35 | suppressed |
| Risperidone | Risperidone | 34 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 33 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 31 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 30 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 30 | suppressed |
| Allopurinol | Allopurinol | 28 | suppressed |
| Diazepam | Diazepam | 28 | suppressed |
| Fluticasone Propionate | Fluticasone Propionate | 28 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 28 | suppressed |
| Lorazepam | Lorazepam | 27 | 12 |
| Topiramate | Topiramate | 27 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 26 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 26 | 17 |
| Paxlovid | Nirmatrelvir/Ritonavir | 26 | 25 |
| Jardiance | Empagliflozin | 25 | suppressed |
| Olanzapine | Olanzapine | 25 | suppressed |
| Spiriva Handihaler | Tiotropium Bromide | 25 | suppressed |
| Vascepa | Icosapent Ethyl | 25 | suppressed |
| Bumetanide | Bumetanide | 24 | suppressed |
| Cefpodoxime Proxetil | Cefpodoxime Proxetil | 24 | suppressed |
| Clonazepam | Clonazepam | 24 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 24 | suppressed |
| Ketoconazole | Ketoconazole | 23 | suppressed |
| Morphine Sulfate | Morphine Sulfate | 22 | 14 |
| Nystatin | Nystatin | 22 | 11 |
| Nystop | Nystatin | 21 | 14 |
| Omeprazole | Omeprazole | 21 | suppressed |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 20 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 19 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 19 | suppressed |
| Latanoprost | Latanoprost | 19 | suppressed |
| Mupirocin | Mupirocin | 18 | 12 |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 17 | suppressed |
| Ceftriaxone | Ceftriaxone Sodium | 17 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 17 | suppressed |
| Levocarnitine | Levocarnitine (With Sugar) | 17 | suppressed |
| Novolin N | Insulin Nph Human Isophane | 17 | suppressed |
| Advair Diskus | Fluticasone Propion/Salmeterol | 16 | suppressed |
| Procrit | Epoetin Alfa | 16 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 15 | suppressed |
| Calcitriol | Calcitriol | 15 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 15 | suppressed |
| Pregabalin | Pregabalin | 15 | suppressed |
| Tramadol Hcl | Tramadol Hcl | 15 | suppressed |
| Alendronate Sodium | Alendronate Sodium | 14 | suppressed |
| Fludrocortisone Acetate | Fludrocortisone Acetate | 14 | suppressed |
| Montelukast Sodium | Montelukast Sodium | 14 | suppressed |
| Atenolol | Atenolol | 13 | suppressed |
| Brimonidine Tartrate | Brimonidine Tartrate | 13 | suppressed |
| Cephalexin | Cephalexin | 13 | suppressed |
| Diltiazem Hcl | Diltiazem Hcl | 13 | suppressed |
| Glipizide | Glipizide | 13 | suppressed |
| Ibuprofen | Ibuprofen | 13 | suppressed |
| Insulin Glargine-Yfgn | Insulin Glargine-Yfgn | 13 | suppressed |
| Isosorbide Mononitrate | Isosorbide Mononitrate | 13 | suppressed |
| Lamotrigine | Lamotrigine | 13 | suppressed |
| Medroxyprogesterone Acetate | Medroxyprogesterone Acetate | 13 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 13 | suppressed |
| Risperdal Consta | Risperidone Microspheres | 13 | suppressed |
| Spironolactone | Spironolactone | 13 | suppressed |
| Xeljanz Xr | Tofacitinib Citrate | 13 | suppressed |
| Acyclovir | Acyclovir | 12 | suppressed |
| Escitalopram Oxalate | Escitalopram Oxalate | 12 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 12 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 12 | suppressed |
| Vyzulta | Latanoprostene Bunod | 12 | suppressed |
| Budesonide | Budesonide | 11 | suppressed |
| Calcium Acetate | Calcium Acetate | 11 | suppressed |
| Cilostazol | Cilostazol | 11 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 11 | suppressed |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 11 | suppressed |
| Ipratropium Bromide | Ipratropium Bromide | 11 | suppressed |
| Lidocaine Hcl | Lidocaine Hcl | 11 | suppressed |
| Morphine Sulfate Er | Morphine Sulfate | 11 | suppressed |
| Potassium Citrate Er | Potassium Citrate | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $22.54 · 1 records | LivaNova USA, Inc. | VNS THERAPY SENTIVA MODEL 1000 GENERATOR | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error